At the end of 2023, the Bulgarian Commission for Protection of Competition (“CPC”) issued a key decision related to an abuse of dominance case in the pharmaceutical sector. The decision, which is expected to have a significant impact on the parallel export of pharmaceuticals, provides a clue to the CPC’s approach when parallel export concerns…

Exhaustion doctrine and parallel imports Parallel imports, Intellectual Property (“IP”) protection and its correlation with antimonopoly regulation  is one of the most discussed topicsin the Russian Federation for the past 15 years. In general, the issue of parallel imports is closely associated with the exhaustion doctrine (that is, once a product protected by IP has…